04:55 PM EST, 02/11/2025 (MT Newswires) -- Edwards Lifesciences ( EW ) reported Q4 adjusted earnings late Tuesday of $0.59 per diluted share, up from $0.55 a year earlier.

Analysts polled by FactSet expected $0.55.

Net sales for the quarter ended Dec. 31 rose to $1.39 billion from $1.27 billion a year earlier.

Analysts surveyed by FactSet expected $1.36 billion.

The company said it expects Q1 adjusted EPS of $0.58 to $0.64 on revenue of $1.35 billion to $1.43 billion. Analysts project EPS of $0.59 on revenue of $1.41 billion.

Edwards said its full-year guidance remains unchanged.

Shares of the company were up about 7% in after-hours activity.